Sanofi-Aventis Groupe

Industry / private company


Location: Paris, France (FR) FR

ISNI: -

ROR: https://ror.org/02n6c9837

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

A cell-based drug delivery platform for treating central nervous system inflammation. (2021) Levy O, Rothhammer V, Mascanfroni I, Tong Z, Kuai R, De Biasio M, Wang Q, et al. Journal article Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database. (2020) Allanore Y, Bozzi S, Terlinden A, Huscher D, Amand C, Soubrane C, Siegert E, et al. Journal article Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: from dermal fibroblasts of patients with scleroderma to tight skin 1 mouse (2020) Ledein L, Léger B, Dees C, Beyer C, Distler A, Vettori S, Boukaiba R, et al. Journal article Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the US (2019) Whichello C, Van Overbeeke E, Janssens R, Bywall KS, Russo S, Veldwijk J, Cleemput I, et al. Journal article Learning Associations Between Clinical Information and Motion-Based Descriptors Using a Large Scale MR-derived Cardiac Motion Atlas (2019) Puyol-Antón E, Ruijsink B, Langet H, De Craene M, Piro P, Schnabel JA, King AP Conference contribution Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA (2019) Janssens R, Russo S, van Overbeeke E, Whichello C, Harding S, Kübler J, Juhaeri J, et al. Journal article The "Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies" (SPRINTT) randomized controlled trial: Case finding, screening and characteristics of eligible participants (2018) Marzetti E, Cesari M, Calvani R, Msihid J, Tosato M, Rodriguez-Manas L, Lattanzio F, et al. Journal article Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies (2018) Baraniak I, Kropff B, Ambrose L, Mcintosh M, Mclean GR, Pichon S, Atkinson C, et al. Journal article Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia (2018) Baraniak I, Kropff B, Mclean GR, Pichon S, Piras-Douce F, Milne RSB, Smith C, et al. Journal article A DREAM challenge to build prediction models for short-term discontinuation of docetaxel in metastatic castration- resistant prostate cancer (2017) Seyednasrollah F, Wang T, Piccolo SR, Vega R, Greiner R, Fuchs C, Gofer E, et al. Journal article
1 2 3